← Eichor
Study identifier: NCT05465200 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lower Silesia Cardiogenic Shock Initiative

Condition: Cardiogenic Shock  ·  Sponsor: Wroclaw Medical University

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

LSCSI is a Hub\&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified protocol defining which cardiogenic shock patient and when should be transferred to the "hub" for enhanced treatment options including durable mechanical circulatory support or heart transplant. The "hub" have 7/24 Shock Team on-site supplied with a protocol how to proceed with "spoke" transferred patients including decision making on which mechanical circulatory support implant with subsequent de-escalation or escalation pathway.

This description comes directly from the study's public registry record.

Talk to the study team

Wiktor Kuliczkowski  ·  +48717331112  ·  wiktor.kuliczkowski@umed.wroc.pl

Mateusz Sokolski  ·  +48717331112  ·  mateusz.sokolski@umed.wroc.pl

Always discuss trial participation with your own doctor first.

Locations (1)

Institute of Heart Disease of Wroclaw Medical UniversityWroclaw, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05465200